About the Authors
- Jost B. Jonas
-
Contributed equally to this work with: Jost B. Jonas, Vinay Nangia
* E-mail: nagpursuraj@gmail.com (VN); Jost.Jonas@augen.ma.uni-heidelberg.de (JBJ)
Affiliations Suraj Eye Institute, Nagpur, India, Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University, Heidelberg, Mannheim, Germany
- Vinay Nangia
-
Contributed equally to this work with: Jost B. Jonas, Vinay Nangia
* E-mail: nagpursuraj@gmail.com (VN); Jost.Jonas@augen.ma.uni-heidelberg.de (JBJ)
Affiliation Suraj Eye Institute, Nagpur, India
- Anshu Khare
-
Affiliation Suraj Eye Institute, Nagpur, India
- Maithili Kulkarni
-
Affiliation Suraj Eye Institute, Nagpur, India
- Arshia Matin
-
Affiliation Suraj Eye Institute, Nagpur, India
- Ajit Sinha
-
Affiliation Suraj Eye Institute, Nagpur, India
- Krishna Bhojwani
-
Affiliation Suraj Eye Institute, Nagpur, India
- Prabhat Nangia
-
Affiliation Suraj Eye Institute, Nagpur, India
- Songhomitra Panda-Jonas
-
Affiliation Suraj Eye Institute, Nagpur, India
Competing Interests
This study was partly supported by the Heidelberg Engineering Co., and Carl Zeiss Meditec Co. JBJ Consultant for Allergan Inc.; MSD; Alimera Co.; Patent holder with CellMed AG, Alzenau, Germany, Patent application number: 20120263794; Patent application title: TREATMENT OF EYE DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING A NEUROPROTECTIVE FACTOR AND/OR AN ANTI-ANGIOGENIC FACTOR. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: JBJ VN SPJ. Performed the experiments: JBJ VN AK MK AM AS KB PN SPJ. Analyzed the data: JBJ VN. Contributed reagents/materials/analysis tools: JBJ VN. Wrote the manuscript: JBJ VN SPJ.